Clinical Trial Update: A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for the VISION5 product in ocular hypertension and primary open-angle glaucoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• VISION5 Product

Snippet

Sponsor: ForSight Vision5, Inc. | Conditions: Ocular Hypertension, Primary Open Angle Glaucoma | Phase 1 | Status: COMPLETED